Editorial
World J Hepatol
16(1):1-11.
Published online Jan 27, 2024.
doi: 10.4254/wjh.v16.i1.1
Abstract (121)
|
Core Tip (134)
|
Full Article (HTML) (889)
|
Figures (1-1) (97)
|
Full Article (PDF)-1204K (60)
|
Full Article with Cover (PDF)-11949K (27)
|
Full Article (XML)-236K (21)
|
Audio-1342K (3)
|
Peer-Review Report-230K (23)
|
Answering Reviewers-97K (17)
|
Received: 10/26/2023
|
Revised: 12/04/2023
|
Accepted: 12/28/2023
|
PubMed Central
|
PubMed
|
CrossRef
|
Google Scholar
|
Times Cited (0)
|
Total Visits (1850)
|
Similar Articles (70)
|
Timeline of Article Publication (1)
|
Authors Evaluation (6)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
World J Hepatol
16(1):12-16.
Published online Jan 27, 2024.
doi: 10.4254/wjh.v16.i1.12
Abstract (116)
|
Core Tip (111)
|
Full Article (HTML) (509)
|
Tables (1-1) (88)
|
Full Article (PDF)-358K (38)
|
Full Article with Cover (PDF)-11106K (31)
|
Full Article (XML)-54K (20)
|
Audio-1072K (6)
|
Peer-Review Report-236K (17)
|
Answering Reviewers-62K (15)
|
Received: 11/09/2023
|
Revised: 12/05/2023
|
Accepted: 12/19/2023
|
PubMed Central
|
PubMed
|
CrossRef
|
Google Scholar
|
Times Cited (0)
|
Total Visits (1306)
|
Similar Articles (17)
|
Timeline of Article Publication (1)
|
Authors Evaluation (5)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
Minireviews
Role of fecal microbiota transplant in management of hepatic encephalopathy: Current trends and future directions
World J Hepatol
16(1):17-32.
Published online Jan 27, 2024.
doi: 10.4254/wjh.v16.i1.17
Abstract (129)
|
Core Tip (111)
|
Full Article (HTML) (1780)
|
Figures (1-2) (79)
|
Tables (1-5) (71)
|
Full Article (PDF)-1655K (91)
|
Full Article with Cover (PDF)-12399K (42)
|
Full Article (XML)-226K (24)
|
Audio-1259K (2)
|
Peer-Review Report-216K (23)
|
Answering Reviewers-145K (19)
|
Received: 09/16/2023
|
Revised: 12/02/2023
|
Accepted: 01/03/2024
|
PubMed Central
|
PubMed
|
CrossRef
|
Google Scholar
|
Times Cited (1)
|
Total Visits (2699)
|
Similar Articles (56)
|
Timeline of Article Publication (0)
|
Authors Evaluation (1)
|
Article Quality Tracking (1)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
World J Hepatol
16(1):33-40.
Published online Jan 27, 2024.
doi: 10.4254/wjh.v16.i1.33
Abstract (138)
|
Core Tip (111)
|
Full Article (HTML) (1154)
|
Figures (1-1) (89)
|
Full Article (PDF)-601K (102)
|
Full Article with Cover (PDF)-11346K (25)
|
Full Article (XML)-89K (17)
|
Audio-384K (3)
|
Peer-Review Report-180K (17)
|
Answering Reviewers-74K (22)
|
Received: 10/10/2023
|
Revised: 11/06/2023
|
Accepted: 01/05/2024
|
PubMed Central
|
PubMed
|
CrossRef
|
Google Scholar
|
Times Cited (2)
|
Total Visits (1965)
|
Similar Articles (320)
|
Timeline of Article Publication (2)
|
Authors Evaluation (1)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
Retrospective Cohort Study
Direct-acting antivirals failed to reduce the incidence of hepatocellular carcinoma occurrence in hepatitis C virus associated cirrhosis: A real-world study
World J Hepatol
16(1):41-53.
Published online Jan 27, 2024.
doi: 10.4254/wjh.v16.i1.41
Abstract (168)
|
Core Tip (126)
|
Article Highlights (135)
|
Full Article (HTML) (1086)
|
Figures (1-4) (95)
|
Tables (1-3) (76)
|
Full Article (PDF)-1672K (51)
|
Full Article with Cover (PDF)-12418K (34)
|
Full Article (XML)-173K (20)
|
Audio-467K (3)
|
Peer-Review Report-182K (20)
|
Answering Reviewers-71K (36)
|
Received: 11/21/2023
|
Revised: 12/18/2023
|
Accepted: 01/09/2024
|
PubMed Central
|
PubMed
|
CrossRef
|
Google Scholar
|
Times Cited (0)
|
Total Visits (2340)
|
Similar Articles (1796)
|
Timeline of Article Publication (2)
|
Authors Evaluation (5)
|
Article Quality Tracking (0)
|
Reader Comments (1)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
Observational Study
Metabolic puzzle: Exploring liver fibrosis differences in Asian metabolic-associated fatty liver disease subtypes
World J Hepatol
16(1):54-64.
Published online Jan 27, 2024.
doi: 10.4254/wjh.v16.i1.54
Abstract (112)
|
Core Tip (123)
|
Article Highlights (151)
|
Full Article (HTML) (813)
|
Figures (1-3) (92)
|
Tables (1-2) (73)
|
Full Article (PDF)-1874K (41)
|
Full Article with Cover (PDF)-12619K (24)
|
Full Article (XML)-114K (18)
|
Audio-386K (4)
|
Peer-Review Report-233K (28)
|
Answering Reviewers-161K (22)
|
Received: 10/02/2023
|
Revised: 10/22/2023
|
Accepted: 12/18/2023
|
PubMed Central
|
PubMed
|
CrossRef
|
Google Scholar
|
Times Cited (1)
|
Total Visits (2297)
|
Similar Articles (14)
|
Timeline of Article Publication (4)
|
Authors Evaluation (2)
|
Article Quality Tracking (0)
|
Reader Comments (1)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
Basic Study
Subcellular distribution of prohibitin 1 in rat liver during liver regeneration and its cellular implication
World J Hepatol
16(1):65-74.
Published online Jan 27, 2024.
doi: 10.4254/wjh.v16.i1.65
Abstract (115)
|
Core Tip (117)
|
Article Highlights (144)
|
Full Article (HTML) (484)
|
Figures (1-4) (91)
|
Full Article (PDF)-5746K (34)
|
Full Article with Cover (PDF)-16492K (25)
|
Full Article (XML)-96K (20)
|
Audio-3997K (4)
|
Peer-Review Report-192K (14)
|
Answering Reviewers-146K (24)
|
Received: 09/30/2023
|
Revised: 11/03/2023
|
Accepted: 11/28/2023
|
PubMed Central
|
PubMed
|
CrossRef
|
Google Scholar
|
Times Cited (0)
|
Total Visits (1409)
|
Similar Articles (39)
|
Timeline of Article Publication (1)
|
Authors Evaluation (1)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
Rifaximin on epigenetics and autophagy in animal model of hepatocellular carcinoma secondary to metabolic-dysfunction associated steatotic liver disease
World J Hepatol
16(1):75-90.
Published online Jan 27, 2024.
doi: 10.4254/wjh.v16.i1.75
Abstract (130)
|
Core Tip (129)
|
Article Highlights (121)
|
Full Article (HTML) (878)
|
Figures (1-4) (71)
|
Tables (1-5) (82)
|
Full Article (PDF)-6006K (52)
|
Full Article with Cover (PDF)-16750K (26)
|
Full Article (XML)-200K (19)
|
Audio-376K (2)
|
Peer-Review Report-182K (19)
|
Answering Reviewers-60K (28)
|
Supplementary Material-355K (24)
|
Received: 11/03/2023
|
Revised: 12/11/2023
|
Accepted: 01/02/2024
|
PubMed Central
|
PubMed
|
CrossRef
|
Google Scholar
|
Times Cited (0)
|
Total Visits (2288)
|
Similar Articles (1648)
|
Timeline of Article Publication (2)
|
Authors Evaluation (2)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
Meta-Analysis
Sorafenib plus transarterial chemoembolization vs sorafenib alone for patients with advanced hepatocellular carcinoma: A systematic review and meta-analysis
World J Hepatol
16(1):91-102.
Published online Jan 27, 2024.
doi: 10.4254/wjh.v16.i1.91
Abstract (113)
|
Core Tip (123)
|
Article Highlights (117)
|
Full Article (HTML) (559)
|
Figures (1-4) (86)
|
Tables (1-4) (87)
|
Full Article (PDF)-5941K (36)
|
Full Article with Cover (PDF)-16687K (18)
|
Full Article (XML)-115K (19)
|
Audio-187K (7)
|
Peer-Review Report-215K (13)
|
Answering Reviewers-37K (21)
|
Received: 10/20/2023
|
Revised: 11/21/2023
|
Accepted: 12/12/2023
|
PubMed Central
|
PubMed
|
CrossRef
|
Google Scholar
|
Times Cited (0)
|
Total Visits (1946)
|
Similar Articles (2189)
|
Timeline of Article Publication (3)
|
Authors Evaluation (5)
|
Article Quality Tracking (1)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
Case Report
World J Hepatol
16(1):103-108.
Published online Jan 27, 2024.
doi: 10.4254/wjh.v16.i1.103
Abstract (120)
|
Core Tip (116)
|
Full Article (HTML) (467)
|
Figures (1-1) (97)
|
Full Article (PDF)-5068K (28)
|
Full Article with Cover (PDF)-15813K (22)
|
Full Article (XML)-63K (14)
|
Audio-811K (0)
|
Peer-Review Report-266K (15)
|
Answering Reviewers-225K (15)
|
Received: 08/25/2023
|
Revised: 10/24/2023
|
Accepted: 12/12/2023
|
PubMed Central
|
PubMed
|
CrossRef
|
Google Scholar
|
Times Cited (0)
|
Total Visits (1451)
|
Similar Articles (3669)
|
Timeline of Article Publication (0)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
Letter to the Editor
Review on article of effects of tenofovir alafenamide and entecavir in chronic hepatitis B virus patients
World J Hepatol
16(1):109-111.
Published online Jan 27, 2024.
doi: 10.4254/wjh.v16.i1.109
Abstract (112)
|
Core Tip (128)
|
Full Article (HTML) (427)
|
Full Article (PDF)-325K (33)
|
Full Article with Cover (PDF)-11079K (25)
|
Full Article (XML)-24K (24)
|
Audio-243K (0)
|
Peer-Review Report-215K (12)
|
Answering Reviewers-19K (12)
|
Received: 10/30/2023
|
Revised: 12/04/2023
|
Accepted: 01/12/2024
|
PubMed Central
|
PubMed
|
CrossRef
|
Google Scholar
|
Times Cited (0)
|
Total Visits (1080)
|
Similar Articles (370)
|
Timeline of Article Publication (3)
|
Authors Evaluation (1)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open